196
Views
1
CrossRef citations to date
0
Altmetric
Review

The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations

Pages 199-207 | Published online: 06 Dec 2019

References

  • Schram MT, Chaturvedi N, Fuller JH, Stehouwer CD, Group EPCS. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study. J Hypertens. 2003;21(11):2035–2044. doi:10.1097/00004872-200311000-0001214597846
  • Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database. Diabetes Care. 2006;29(4):798–804. doi:10.2337/diacare.29.04.06.dc05-143316567818
  • Larsson SC, Wallin A, Hakansson N, Stackelberg O, Back M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol. 2018;262:66–70. doi:10.1016/j.ijcard.2018.03.09929605469
  • Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59(12):3216–3222. doi:10.2337/db10-086220739685
  • Jansson RW, Hufthammer KO, Krohn J. Diabetic retinopathy in type 1 diabetes patients in Western Norway. Acta Ophthalmol. 2018;96(5):465–474. doi:10.1111/aos.2018.96.issue-529369506
  • Dorman JS, Laporte RE, Kuller LH, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984;33(3):271–276. doi:10.2337/diab.33.3.2716698317
  • Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19(10):86. doi:10.1007/s11892-019-1212-831456118
  • Shah VN, Harrall KK, Shah CS, et al. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos Int. 2017;28(9):2601–2610. doi:10.1007/s00198-017-4097-x28580510
  • Krause MP, Riddell MC, Hawke TJ. Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms. Pediatr Diabetes. 2011;12(4 Pt 1):345–364. doi:10.1111/j.1399-5448.2010.00699.x20860561
  • Tikkanen-Dolenc H, Waden J, Forsblom C, et al. Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes. Diabetologia. 2017;60(3):574–580. doi:10.1007/s00125-016-4189-828013340
  • Bohn B, Herbst A, Pfeifer M, et al. Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care. 2015;38(8):1536–1543. doi:10.2337/dc15-003026015557
  • Tielemans SM, Soedamah-Muthu SS, De Neve M, et al. Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB prospective complications study. Diabetologia. 2013;56(1):82–91. doi:10.1007/s00125-012-2743-623052062
  • Waden J, Forsblom C, Thorn LM, et al. Physical activity and diabetes complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) study. Diabetes Care. 2008;31(2):230–232. doi:10.2337/dc07-123817959867
  • Mason NJ, Jenkins AJ, Best JD, Rowley KG. Exercise frequency and arterial compliance in non-diabetic and type 1 diabetic individuals. Eur J Cardiovasc Prev Rehabil. 2006;13(4):598–603. doi:10.1097/01.hjr.0000216546.07432.b216874151
  • Pongrac Barlovic D, Tikkanen-Dolenc H, Groop PH. Physical activity in the prevention of development and progression of kidney disease in type 1 diabetes. Curr Diab Rep. 2019;19(7):41. doi:10.1007/s11892-019-1157-y31152254
  • Kriska AM, LaPorte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study–VII. J Clin Epidemiol. 1991;44(11):1207–1214. doi:10.1016/0895-4356(91)90153-Z1941015
  • Moy CS, Songer TJ, LaPorte RE, et al. Insulin-dependent diabetes mellitus, physical activity, and death. Am J Epidemiol. 1993;137(1):74–81. doi:10.1093/oxfordjournals.aje.a1166048434575
  • LaPorte RE, Dorman JS, Tajima N, et al. Pittsburgh Insulin-dependent Diabetes Mellitus Morbidity and Mortality study: physical activity and diabetic complications. Pediatrics. 1986;78(6):1027–1033.3786027
  • Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P. What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia. 2012;55(3):542–551. doi:10.1007/s00125-011-2403-222189486
  • Yardley JE, Hay J, Abou-Setta AM, Marks SD, McGavock J. A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes. Diabetes Res Clin Pract. 2014;106(3):393–400. doi:10.1016/j.diabres.2014.09.03825451913
  • Yardley JE, Kenny GP, Perkins BA, et al. Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes. Diabetes Care. 2013;36(3):537–542. doi:10.2337/dc12-096323172972
  • Plotnikoff RC, Taylor LM, Wilson PM, et al. Factors associated with physical activity in Canadian adults with diabetes. Med Sci Sports Exerc. 2006;38(8):1526–1534. doi:10.1249/01.mss.0000228937.86539.9516888470
  • McCarthy MM, Whittemore R, Grey M. Physical activity in adults with type 1 diabetes. Diabetes Educ. 2016;42(1):108–115. doi:10.1177/014572171562002126655391
  • Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care. 2008;31(11):2108–2109. doi:10.2337/dc08-072018689694
  • Allen F, Stillman E, Fitz R. Total Dietary Regulation in the Treatment of Diabetes. Ithaca, NY: Monographs of the Rockefeler Institute for Medical Research; 1919.
  • Lawrence RD. The effect of exercise on insulin action in diabetes. Br Med J. 1926;1(3406):648–650. doi:10.1136/bmj.1.3406.64820772477
  • Zinman B, Murray FT, Vranic M, et al. Glucoregulation during moderate exercise in insulin treated diabetics. J Clin Endocrinol Metab. 1977;45(4):641–652. doi:10.1210/jcem-45-4-641914970
  • Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care. 2001;24(4):625–630. doi:10.2337/diacare.24.4.62511315820
  • Moser O, Tschakert G, Mueller A, et al. Effects of high-intensity interval exercise versus moderate continuous exercise on glucose homeostasis and hormone response in patients with type 1 diabetes mellitus using novel ultra-long-acting insulin. PLoS ONE. 2015;10(8):e0136489. doi:10.1371/journal.pone.013648926317981
  • Dube MC, Weisnagel SJ, Prud’homme D, Lavoie C. Exercise and newer insulins: how much glucose supplement to avoid hypoglycemia? Med Sci Sports Exerc. 2005;37(8):1276–1282. doi:10.1249/01.mss.0000174950.25188.3616118572
  • Franc S, Daoudi A, Pochat A, et al. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab. 2015;17(12):1150–1157. doi:10.1111/dom.2015.17.issue-1226264812
  • Sonnenberg GE, Kemmer FW, Berger M. Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia. Diabetologia. 1990;33(11):696–703. doi:10.1007/BF004005722076801
  • West DJ, Morton RD, Bain SC, Stephens JW, Bracken RM. Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes. J Sports Sci. 2010;28(7):781–788. doi:10.1080/0264041100373409320496226
  • West DJ, Stephens JW, Bain SC, et al. A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci. 2011;29(3):279–289. doi:10.1080/02640414.2010.53175321154013
  • Zaharieva DP, McGaugh S, Pooni R, Vienneau T, Ly T, Riddell MC. Improved open-loop glucose control with basal insulin reduction 90 minutes before aerobic exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Care. 2019;42(5):824–831. doi:10.2337/dc18-220430796112
  • Roy-Fleming A, Taleb N, Messier V, et al. Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: a randomized crossover trial. Diabetes Metab. 2019;45(3):294–300. doi:10.1016/j.diabet.2018.08.00230165156
  • Riddell MC, Gallen IW, Smart CE, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2017;5(5):377–390. doi:10.1016/S2213-8587(17)30014-128126459
  • Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the american diabetes association. Diabetes Care. 2016;39(11):2065–2079. doi:10.2337/dc16-172827926890
  • Yardley JE, Colberg SR. Update on management of type 1 diabetes and type 2 diabetes in athletes. Curr Sports Med Rep. 2017;16(1):38–44. doi:10.1249/JSR.000000000000032728067740
  • Shetty VB, Fournier PA, Davey RJ, et al. The time lag prior to the rise in glucose requirements to maintain stable glycaemia during moderate exercise in a fasted insulinaemic state is of short duration and unaffected by the level at which glycaemia is maintained in Type 1 diabetes. Diabet Med. 2018;35(10):1404–1411. doi:10.1111/dme.2018.35.issue-1029939421
  • Riddell MC, Pooni R, Yavelberg L, et al. Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes. Diabetes Res Clin Pract. 2019;148:137–143. doi:10.1016/j.diabres.2019.01.00330641168
  • Scott SN, Cocks M, Andrews RC, et al. High-intensity interval training improves aerobic capacity without a detrimental decline in blood glucose in people with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(2):604–612. doi:10.1210/jc.2018-0130930281094
  • Soon WHK, Guelfi KJ, Davis EA, Smith GJ, Jones TW, Fournier PA. Effect of combining pre-exercise carbohydrate intake and repeated short sprints on the blood glucose response to moderate-intensity exercise in young individuals with Type 1 diabetes. Diabet Med. 2019;36(5):612–619. doi:10.1111/dme.2019.36.issue-530701617
  • Guelfi KJ, Jones TW, Fournier PA. The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care. 2005;28(6):1289–1294. doi:10.2337/diacare.28.6.128915920041
  • Maran A, Pavan P, Bonsembiante B, et al. Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther. 2010;12(10):763–768. doi:10.1089/dia.2010.003820807120
  • Iscoe KE, Riddell MC. Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with Type 1 diabetes mellitus. Diabet Med. 2011;28(7):824–832. doi:10.1111/j.1464-5491.2011.03274.x21388440
  • Dube MC, Lavoie C, Weisnagel SJ. Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM. Med Sci Sports Exerc. 2013;45(1):3–7. doi:10.1249/MSS.0b013e31826c6ad322895370
  • Campbell MD, West DJ, Bain SC, et al. Simulated games activity vs continuous running exercise: a novel comparison of the glycemic and metabolic responses in T1DM patients. Scand J Med Sci Sports. 2015;25(2):216–222. doi:10.1111/sms.2015.25.issue-224593125
  • Zaharieva D, Yavelberg L, Jamnik V, Cinar A, Turksoy K, Riddell MC. The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous versus circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Technol Ther. 2017;19(6):370–378. doi:10.1089/dia.2017.001028613947
  • Zaharieva DP, Cinar A, Yavelberg L, Jamnik V, Riddell MC. No disadvantage to insulin pump off vs pump on during intermittent high-intensity exercise in adults with type 1 diabetes. Can J Diabetes. 2019. doi:10.1016/j.jcjd.2019.05.015
  • Purdon C, Brousson M, Nyveen SL, et al. The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects. J Clin Endocrinol Metab. 1993;76(3):566–573. doi:10.1210/jcem.76.3.84450128445012
  • Mitchell TH, Abraham G, Schiffrin A, Leiter LA, Marliss EB. Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion. Diabetes Care. 1988;11(4):311–317. doi:10.2337/diacare.11.4.3113042306
  • Sigal RJ, Fisher SJ, Halter JB, Vranic M, Marliss EB. Glucoregulation during and after intense exercise: effects of beta-adrenergic blockade in subjects with type 1 diabetes mellitus. J Clin Endocrinol Metab. 1999;84(11):3961–3971. doi:10.1210/jcem.84.11.611610566635
  • Sigal RJ, Fisher SJ, Manzon A, et al. Glucoregulation during and after intense exercise: effects of alpha-adrenergic blockade. Metabolism. 2000;49(3):386–394. doi:10.1016/S0026-0495(00)90374-310726919
  • Sigal RJ, Purdon C, Fisher SJ, Halter JB, Vranic M, Marliss EB. Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1994;79(4):1049–1057. doi:10.1210/jcem.79.4.79622737962273
  • Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes. 2002;51(Suppl 1):S271–283. doi:10.2337/diabetes.51.2007.S27111815492
  • Fahey AJ, Paramalingam N, Davey RJ, Davis EA, Jones TW, Fournier PA. The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2012;97(11):4193–4200. doi:10.1210/jc.2012-160422962428
  • Bally L, Zueger T, Buehler T, et al. Metabolic and hormonal response to intermittent high-intensity and continuous moderate intensity exercise in individuals with type 1 diabetes: a randomised crossover study. Diabetologia. 2016;59(4):776–784. doi:10.1007/s00125-015-3854-726739816
  • Yardley JE, Kenny GP, Perkins BA, et al. Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care. 2012;35(4):669–675. doi:10.2337/dc11-184422374639
  • Rempel M, Yardley JE, MacIntosh A, et al. Vigorous intervals and hypoglycemia in type 1 diabetes: a randomized cross over trial. Sci Rep. 2018;8(1):15879. doi:10.1038/s41598-018-34342-630367116
  • Canadian Society for Exercise Physiology. Canadian physical activity guidelines for adults – 18–64 years Ottawa, Ontario; 2011 Available at: http://csep.ca/CMFiles/Guidelines/CSEP_PAGuidelines_0-65plus_en.pdf.
  • Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–1359. doi:10.1249/MSS.0b013e318213fefb21694556
  • Yardley JE, Brockman NK, Bracken RM. Could age, sex and physical fitness affect blood glucose responses to exercise in type 1 diabetes? Front Endocrinol (Lausanne). 2018;9:674. doi:10.3389/fendo.2018.0067430524371
  • Brockman NK, Yardley JE. Sex-related differences in fuel utilization and hormonal response to exercise: implications for individuals with type 1 diabetes. Appl Physiol Nutr Metab. 2018;43(6):541–552. doi:10.1139/apnm-2017-055929420905
  • Frid A, Ostman J, Linde B. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care. 1990;13(5):473–477. doi:10.2337/diacare.13.5.4732190773
  • Davis SN, Galassetti P, Wasserman DH, Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes. 2000;49(1):73–81. doi:10.2337/diabetes.49.1.7310615952
  • Ronnemaa T, Koivisto VA. Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients. Diabetes Care. 1988;11(10):769–773. doi:10.2337/diacare.11.10.7693073067
  • Toghi-Eshghi SR, Yardley JE. Morning (fasting) vs afternoon resistance exercise in individuals with type 1 diabetes: a randomized crossover study. J Clin Endocrinol Metab. 2019;104(11):5217–5224. doi:10.1210/jc.2018-0238431211392
  • Yardley J. Effect of morning (fasting) versus afternoon high intensity intermittent exercise on blood glucose in type 1 diabetes. Diabetes. 2019;68(Suppl 1):751–P. doi:10.2337/db19-751-P
  • Ruegemer JJ, Squires RW, Marsh HM, et al. Differences between prebreakfast and late afternoon glycemic responses to exercise in IDDM patients. Diabetes Care. 1990;13(2):104–110. doi:10.2337/diacare.13.2.1042190767
  • Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93. doi:10.1080/09674845.2012.1200244322872934
  • DCCT Study Group. The Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC Publications). Available from: https://portal.bsc.gwu.edu/documents/82966/28932550/2018+NOV+21+DCCT-EDIC+P+and+P+List.pdf/961d1dfd-4db7-4759-a4e5-5f35da56a35a. Accessed 10 10, 2019.
  • Houlder SK, Yardley JE. Continuous glucose monitoring and exercise in type 1 diabetes: past, present and future. Biosensors (Basel). 2018;8:3.
  • Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603. doi:10.2337/dci19-002831177185
  • Adamo M, Codella R, Casiraghi F, et al. Active subjects with autoimmune type 1 diabetes have better metabolic profiles than sedentary controls. Cell Transplant. 2017;26(1):23–32. doi:10.3727/096368916X69302227983910
  • Dyck RA, Kleinman NJ, Funk DR, Yeung RO, Senior P, Yardley JE. We can work (it) out together: type 1 diabetes boot camp for adult patients and providers improves exercise self-efficacy. Can J Diabetes. 2018;42(6):619–625. doi:10.1016/j.jcjd.2018.02.00629909966
  • Radermecker RP, Fayolle C, Brun JF, Bringer J, Renard E. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion. Diabetes Metab. 2013;39(3):258–262. doi:10.1016/j.diabet.2012.12.00423522730
  • Yardley JE, Sigal RJ, Kenny GP, Riddell MC, Lovblom LE, Perkins BA. Point accuracy of interstitial continuous glucose monitoring during exercise in type 1 diabetes. Diabetes Technol Ther. 2013;15(1):46–49. doi:10.1089/dia.2012.018223137050
  • Bally L, Zueger T, Pasi N, Carlos C, Paganini D, Stettler C. Accuracy of continuous glucose monitoring during differing exercise conditions. Diabetes Res Clin Pract. 2016;112:1–5. doi:10.1016/j.diabres.2015.11.01226739116
  • Moser O, Mader JK, Tschakert G, et al. Accuracy of continuous glucose monitoring (cgm) during continuous and high-intensity interval exercise in patients with type 1 diabetes mellitus. Nutrients. 2016;8:8. doi:10.3390/nu8080489
  • Aberer F, Hajnsek M, Rumpler M, et al. Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes. Diabetes Obes Metab. 2017;19(7):1051–1055. doi:10.1111/dom.1290728205324
  • Battelino T, Nimri R, Dovc K, Phillip M, Bratina N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(6):764–770. doi:10.2337/dc16-258428351897
  • Dovc K, Macedoni M, Bratina N, et al. Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial. Diabetologia. 2017;60:2157–2167. doi:10.1007/s00125-017-4395-z28840263
  • Breton MD, Chernavvsky DR, Forlenza GP, et al. Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study. Diabetes Care. 2017;40(12):1644–1650. doi:10.2337/dc17-088328855239
  • Patel NS, Van Name MA, Cengiz E, et al. Mitigating reductions in glucose during exercise on closed-loop insulin delivery: the Ex-Snacks study. Diabetes Technol Ther. 2016;18(12):794–799. doi:10.1089/dia.2016.031127996320
  • Taleb N, Emami A, Suppere C, et al. Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial. Diabetologia. 2016;59(12):2561–2571. doi:10.1007/s00125-016-4107-027704167
  • Breton MD, Brown SA, Karvetski CH, et al. Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. Diabetes Technol Ther. 2014;16(8):506–511. doi:10.1089/dia.2013.033324702135
  • Dovc K, Piona C, Yesiltepe Mutlu G, et al. Faster compared with standard insulin aspart during day-and-night fully closed-loop insulin therapy in type 1 diabetes: a double-blind randomized crossover trial. Diabetes Care. 2019:dc190895 (in press). doi:10.2337/dc19-0895.31575640
  • Jacobs PG, El Youssef J, Reddy R, et al. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy. Diabetes Obes Metab. 2016;18(11):1110–1119. doi:10.1111/dom.2016.18.issue-1127333970
  • Saunders A, Messer LH, Forlenza GP. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy. Expert Rev Med Devices. 2019;1–9.
  • Bekiari E, Kitsios K, Thabit H, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018;361:k1310. doi:10.1136/bmj.k131029669716
  • Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(7):501–512. doi:10.1016/S2213-8587(17)30167-528533136
  • Colberg SR, Laan R, Dassau E, Kerr D. Physical activity and type 1 diabetes: time for a rewire? J Diabetes Sci Technol. 2015;9(3):609–618. doi:10.1177/193229681456623125568144
  • Riddell MC, Zaharieva DP, Yavelberg L, Cinar A, Jamnik VK. Exercise and the development of the artificial pancreas: one of the more difficult series of hurdles. J Diabetes Sci Technol. 2015;9(6):1217–1226. doi:10.1177/193229681560937026428933
  • Moser O, Yardley JE, Bracken RM. Interstitial glucose and physical exercise in type 1 diabetes: integrative physiology, technology, and the gap in-between. Nutrients. 2018;10:1. doi:10.3390/nu10010093
  • Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–238. doi:10.1056/NEJM20000727343040110911004
  • Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes. 2002;51(7):2148–2157. doi:10.2337/diabetes.51.7.214812086945
  • Rickels MR, Mueller R, Teff KL, Naji A. {beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab. 2010;95(3):1238–1246. doi:10.1210/jc.2009-228920097708
  • Rickels MR, Schutta MH, Mueller R, et al. Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes. 2005;54(11):3205–3211. doi:10.2337/diabetes.54.11.320516249446
  • Rickels MR, Peleckis AJ, Markmann E, et al. Long-term improvement in glucose control and counterregulation by islet transplantation for type 1 diabetes. J Clin Endocrinol Metab. 2016;101(11):4421–4430. doi:10.1210/jc.2016-164927571180
  • Yardley JE, Rees JL, Funk DR, Toghi-Eshghi SR, Boule NG, Senior PA. Effects of moderate cycling exercise on blood glucose regulation following successful clinical islet transplantation. J Clin Endocrinol Metab. 2019;104(2):493–502. doi:10.1210/jc.2018-0149830403817
  • Codella R, Adamo M, Maffi P, Piemonti L, Secchi A, Luzi L. Ultra-marathon 100 km in an islet-transplanted runner. Acta Diabetol. 2017;54(7):703–706. doi:10.1007/s00592-016-0938-x27878382
  • Vantyghem MC, de Koning EJP, Pattou F, Rickels MR. Advances in beta-cell replacement therapy for the treatment of type 1 diabetes. Lancet. 2019;394(10205):1274–1285. doi:10.1016/S0140-6736(19)31334-031533905
  • List of sportspeople with diabetes. Available from: https://en.wikipedia.org/wiki/List_of_sportspeople_with_diabetes. Accessed 1015, 2019.